Insmed (INSM) PT Raised to $195 at Mizuho
Mizuho analyst Graig Suvannavejh raised the price target on Insmed (NASDAQ: INSM) to $195.00 (from $192.00) while maintaining a Outperform ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
